|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 37 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SGEN |
Seagen Inc |
Director |
|
2006-08-03 |
4 |
B |
$4.00 |
$74,079 |
I/I |
18,535 |
3,729,500 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-08-03 |
4/A |
B |
$4.00 |
$74,079 |
I/I |
18,535 |
3,753,076 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-05 |
4 |
B |
$29.96 |
$558,037 |
I/I |
18,597 |
1,480,469 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-03-13 |
4 |
B |
$8.69 |
$163,349 |
I/I |
18,792 |
2,200,995 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-28 |
4 |
S |
$19.90 |
$378,393 |
I/I |
(18,855) |
122,122 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-22 |
4 |
B |
$8.78 |
$165,623 |
I/I |
18,869 |
3,833,433 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-27 |
4 |
S |
$21.58 |
$413,293 |
I/I |
(19,030) |
140,977 |
|
- |
|
INCY |
Incyte Corp |
Director |
|
2010-09-21 |
4 |
S |
$14.94 |
$288,265 |
I/I |
(19,291) |
250,358 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-15 |
4 |
B |
$7.50 |
$145,005 |
I/I |
19,334 |
6,489,444 |
1.5 |
- |
|
INCY |
Incyte Corp |
Director |
|
2010-09-21 |
4 |
S |
$14.94 |
$290,387 |
I/I |
(19,433) |
252,213 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-08 |
4 |
B |
$30.36 |
$592,489 |
I/I |
19,513 |
8,255,421 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-05-09 |
4 |
B |
$29.90 |
$584,367 |
I/I |
19,547 |
232,924 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-29 |
4 |
B |
$29.06 |
$568,144 |
I/I |
19,552 |
1,449,137 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2007-02-14 |
4/A |
S |
$8.76 |
$171,354 |
I/I |
(19,561) |
75,598 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2007-02-14 |
4 |
S |
$8.72 |
$170,572 |
I/I |
(19,561) |
75,598 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-23 |
4 |
B |
$6.95 |
$136,305 |
I/I |
19,608 |
6,518,845 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-23 |
4 |
S |
$14.86 |
$292,277 |
I/I |
(19,670) |
492,775 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-29 |
4 |
S |
$14.93 |
$293,693 |
I/I |
(19,670) |
418,030 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-10 |
4 |
B |
$25.56 |
$511,150 |
I/I |
20,000 |
5,674,104 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-09-30 |
4 |
B |
$18.08 |
$366,140 |
I/I |
20,210 |
1,896,735 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-02-08 |
4 |
B |
$8.94 |
$182,205 |
I/I |
20,242 |
3,859,485 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-06-29 |
4 |
B |
$4.08 |
$82,922 |
I/I |
20,340 |
1,393,058 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-02 |
4 |
S |
$11.88 |
$241,654 |
I/I |
(20,346) |
1,269,093 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-11 |
4 |
B |
$5.28 |
$107,365 |
I/I |
20,347 |
608,349 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-12-05 |
4 |
B |
$28.39 |
$582,072 |
I/I |
20,456 |
6,901,703 |
2.25 |
- |
|
1397 Records found
|
|
Page 37 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|